A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All

Post author:gtmrick
Post published:June 13, 2015
Post category:Uncategorized

A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All. Continue reading at Motherboard Vice.

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

You Might Also Like

36th Annual JPM Healthcare Conference

Vasomune Announces Preliminary Positive Phase 1 Clinical Trial Results for Vascular Normalization Therapy

Vasomune Receives a US $2.8 Million PRMRP Grant from the US Department of Defense to Develop AV-001 for the Treatment of ALI/ARDS of Any Cause, Including COVID-19

About

Vasomune Therapeutics 2020 © All Rights Reserved.